SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – AXE, CISN, IPHS, PGNX
If you are an Anixter shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/anixter-international-inc-axe-stock-merg... .
NEW YORK, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:
Anixter International Inc. (NYSE: AXE)
The investigation concerns whether Anixter and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Anixter to an affiliate of Clayton, Dubilier & Rice. If you are an Anixter shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/anixter-international-inc-axe-stock-merger-clayton-dubilier/.
Cision Ltd. (NYSE: CISN)
The investigation concerns whether Cision and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Cision to an affiliate of Platinum Equity for $10.00 per share. If you are a Cision shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/cision-ltd-cisn-stock-merger-platinum-equity/.
Innophos Holdings, Inc. (NASDAQ: IPHS)
The investigation concerns whether Innophos and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Innophos to an affiliate of One Rock Capital Partners, LLC for $32.00 per share. If you are an Innophos shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/innophos-holdings-inc-iphs-stock-merger-one-rock/.
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)
The investigation concerns whether Progenics and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Progenics to Lantheus Holdings, Inc. If you are a Progenics shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/progenics-pharmaceuticals-inc-pgnx-stock-merger-lantheus/.
On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
